Navigation Links
Testing for blood sugar levels made easier

The foundation of diabetics care is the regular monitoring of blood sugar levels. But doctors say that many patients do not adhere to this routine because of inconvenience or discomfort, as this requires multiple blood samples to be taken by puncturing// their fingers or forearm. However, researchers from University of Texas have discovered a new non-invasive test, using optical coherence tomography, which will end the pain of pricking for diabetes patients.

Optical Coherence Tomography uses advanced photonics and fiber optics to obtain images of tissues. It uses infrared light waves that reflect off the internal structures within tissues to send back a picture and information about the tissue, in this case, including blood sugar levels.

A pilot study of OCT was done on 15 healthy volunteers when images of the left forearm were taken every 10 to 20 seconds for over three hours. Doctors took 420 blood glucose measurements from the volunteers using blood analysis for comparison. They also recorded 8,435 OCT images.

Researchers at the end of the pilot study concluded that OCT was an effective non-invasive, real-time, sensitive monitoring technique for assessment of blood glucose concentration in human subjects during an OGTT (oral glucose tolerance test). The high quality resolution of images and accuracy are the advantages of the OCT approach, which needs more studies to validate the results.


'"/>




Page: 1

Related medicine news :

1. First Vaccine Designed for Africa Cleared for Testing in Humans
2. Laboratory Testing Can Identify Risk of Pre-Term Labor and Delivery
3. DNA Testing For More Accurate Results
4. SARS vaccine shows promise in Animal Testing
5. Testing Of Saliva May Predict Dental Caries
6. Diagnosing Sleep Apnea By Overnight Sleep Testing Method
7. Testing genes for disease does not cause harm to children of people with Alzheimers
8. Testing Your Health & Charging Your Mobile At One Go - Check Out The Urine Powered Batteries
9. Testing For HIV/AIDS Compulsory For New Military Recruits
10. Japanese And Chinese Pharmaceutical Companies Join Together In Drug Testing
11. Eye Diseases Diagnosed Through Genetical Testing
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... Yardley, PA (PRWEB) , ... March 23, 2017 ... ... received Patient Oriented Disease Management Accreditation from the NCQA. The accreditation covers StayWell’s ... programs. , Accredited status is granted to organizations that have excellent programs ...
(Date:3/23/2017)... ... , ... The TouchPoint Solution, home of Buzzies *, is boosting the ... , “Buzzies change the way we interact with stress and live our day-to-day lives,” ... date in December 2016, The TouchPoint Solution has sold more than $750,000 in product ...
(Date:3/23/2017)... , ... March 23, 2017 , ... After raising more ... FaceCradle , the most-funded travel pillow in crowdfunding history, has established a ... its wildly popular travel innovation to Americans. , “We’re excited to be operating on ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... today announced rapid completion of the strategic executive team expansion needed to further ... to the ChenMed executive team,” says Christopher Chen, MD, ChenMed Chief Executive Officer. ...
(Date:3/23/2017)... ... March 23, 2017 , ... Natural Subsistence, ... aspects of people’s health and nutrition, announced its product Leyzene is now available ... Subsistence develops nutritional supplements that help people improve all aspects of their health ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... MUMBAI , March 23, 2017 ... de Piramal Enterprises Limited, anuncia el nombramiento de ... PPS ofrece una plataforma de servicios integrados completa ... Needleman desempeñará un cargo clave en el crecimiento ... comercial, Needleman será responsable de impulsar todas las ...
(Date:3/23/2017)... 23, 2017  Galmed Pharmaceuticals Ltd. (Nasdaq: ... clinical-stage biopharmaceutical company focused on the development of ... nonalcoholic steatohepatitis, or NASH, and other liver diseases, ... twelve months ended December 31, 2016, and announced new ... demonstrating Aramchol™,s potential direct effect on liver fibrosis. ...
(Date:3/23/2017)... 23, 2017 ReNeuron reported in December ... in chronic stroke patients, despite not meeting the three-month time ... the Action Research Arm Test (ARAT). As a result, the ... controlled clinical study in 2017. Beyond CTX, we expect safety ... 2017 and Phase I data from its critical limb ischaemia ...
Breaking Medicine Technology: